Can High Blood Pressure Cause Retinal Detachment?

Discover how high blood pressure affects your vision and its potential to cause serious eye conditions like retinal detachment. Protect your eye health.

Severely elevated blood pressure can cause a specific type of retinal detachment, though not the kind most people picture when they hear the term. The detachment linked to hypertension is called serous or exudative retinal detachment, where fluid leaks beneath the retina and lifts it away from the underlying tissue. It differs fundamentally from the more common tear-based (rhegmatogenous) detachment, and the good news is that it usually reverses once blood pressure comes under control. The relationship between hypertension and the eye, however, is more complex and more consequential than a simple yes-or-no framing suggests.

How High Blood Pressure Damages the Back of the Eye

Your retina depends on a dense network of tiny blood vessels for its oxygen and nutrient supply. These vessels sit in two layers: the retinal circulation, which feeds the inner retina, and the choroidal circulation, which feeds the outer retina and the retinal pigment epithelium (RPE), a single-cell layer that acts as a barrier between the retina and the blood supply beneath it. When blood pressure spikes to dangerous levels, both of these vascular beds take damage, but the choroid is where retinal detachment originates.

In severe hypertension, the body releases vasoconstrictor chemicals that squeeze blood vessels tight. In the choroid, this constriction leads to a chain reaction: the small vessels go into spasm, their walls break down, and blood flow to the RPE drops sharply. The RPE cells, starved of oxygen, stop functioning as a barrier. Fluid that normally stays beneath the retina begins leaking into the subretinal space, pooling there and physically pushing the retina upward. This is serous retinal detachment, and it is driven entirely by fluid accumulation rather than a physical tear in the retina.

The ischemic damage to the RPE also produces characteristic marks visible during an eye exam. Elschnig spots, small pale patches surrounded by dark pigment, are a hallmark of severe hypertensive choroidopathy and represent localized areas where the RPE has died from lack of blood flow.

Serous Detachment Versus the Detachment You’ve Heard About

When most people think of retinal detachment, they think of the emergency where the retina tears and peels away from the back of the eye, requiring urgent surgery. That is rhegmatogenous retinal detachment, and it happens for reasons unrelated to blood pressure: aging changes in the vitreous gel, trauma, high myopia, or prior eye surgery. Hypertension does not cause this type.

The serous (exudative) detachment caused by hypertension involves no tear at all. The retina remains intact but gets lifted off by fluid from below. On imaging, the two types look distinct. Exudative detachments tend to show features like undulations in the RPE and hyperreflective material in the subretinal fluid, while rhegmatogenous detachments show corrugations in the outer retina and more swelling within the retinal layers themselves.

The distinction matters for treatment. Rhegmatogenous detachment needs surgery. Serous detachment from hypertension needs blood pressure control. Getting the diagnosis wrong in either direction leads to the wrong treatment plan.

How High Does Blood Pressure Need to Be?

Serous retinal detachment from hypertension is not a complication of mildly or moderately elevated blood pressure. It occurs in the setting of malignant hypertension, sometimes called hypertensive emergency, where pressures reach extreme levels and organs are actively taking damage. The blood pressure readings in published cases are striking. One patient presented with bilateral serous retinal detachments and a blood pressure of 230/130 mmHg.

Another presented at 206/125 mmHg with severe vision loss in both eyes.

In one study of patients with malignant hypertension, serous retinal detachment was found in about 60% of cases. All of those patients also had retinal hemorrhages, and the detachment correlated with kidney damage: patients who developed serous detachments had significantly higher levels of protein in their urine, a sign that the same vascular injury happening in the eye was also happening in the kidneys.

If you have well-controlled or stage 1 hypertension (readings in the 130-140/80-90 range), serous retinal detachment is not on the table. Long-term moderate hypertension does cause gradual changes to retinal blood vessels, including narrowing, crossing defects, and subtle damage that an eye doctor can see during a routine exam. But the dramatic fluid-under-the-retina scenario belongs to the extreme end of the spectrum.

When Vision Loss Is the First Warning Sign

One of the unsettling aspects of hypertensive serous detachment is that blurred or lost vision can be the reason a person seeks medical care in the first place, revealing dangerously high blood pressure that was previously undiagnosed. The eye, in these cases, is functioning as an early warning system for a body-wide crisis.

A 50-year-old man who showed up with painless vision loss and a dull headache turned out to have blood pressure of 206/125 mmHg and bilateral serous retinal detachments. He had no prior diagnosis of hypertension.

In another case, a woman presented with sudden visual decline that led clinicians to discover her blood pressure was 230/130 mmHg.

Because the retinal detachment in these cases is bilateral, affecting both eyes, and painless, it can initially be mistaken for other conditions. But the combination of severely elevated blood pressure, bilateral serous detachments, and characteristic choroidal findings makes the diagnosis straightforward once blood pressure is checked. The broader lesson is that any sudden, unexplained change in vision warrants a blood pressure reading, especially if both eyes are affected.

Pregnancy, Preeclampsia, and the Retina

Pregnant women represent a specific group at risk for hypertensive serous retinal detachment, most commonly in the context of preeclampsia or its more severe variant, HELLP syndrome. Preeclampsia involves hypertension and organ dysfunction that develops during pregnancy, and while most of the clinical focus centers on the kidneys and liver, the eyes are not spared.

Serous retinal detachment in preeclampsia is uncommon but well-documented. It can develop during the pregnancy or, in some cases, within hours after delivery.

The mechanism is the same as in other forms of malignant hypertension: choroidal ischemia disrupts the RPE barrier and fluid accumulates beneath the retina. Imaging in these cases shows dramatically thickened choroids, with measurements exceeding 800 micrometers in one reported case, far beyond the normal range.

The reassuring finding is that vision tends to recover fully after the hypertension is managed, whether through delivery or blood pressure treatment. In one case involving suspected HELLP syndrome, the patient’s vision returned to normal within four months following urgent delivery and blood pressure control.

Exudative retinal detachment in a pregnant patient should always trigger an evaluation for preeclampsia if it has not already been diagnosed.

Hidden Tumors That Drive the Blood Pressure Up

Sometimes the dangerously high blood pressure behind a serous retinal detachment is itself a symptom of something else. Pheochromocytomas and paragangliomas are rare tumors, usually found on or near the adrenal glands, that secrete large amounts of stress hormones like adrenaline and noradrenaline. These hormones drive blood pressure to extreme levels, and the resulting hypertensive choroidopathy can produce bilateral serous retinal detachments.

A 28-year-old woman who developed bilateral blindness was found to have a pheochromocytoma. Her eye exam showed severe hypertensive retinopathy with exudative retinal detachments in both eyes, and the underlying tumor was only discovered after the eye findings prompted further investigation.

Similar cases have been reported in children as well. One child with malignant hypertension and bilateral serous retinal detachments was ultimately found to have a pheochromocytoma as the cause.

Hypertensive choroidopathy has also been reported in the setting of adrenal carcinoma, another tumor capable of producing hormones that elevate blood pressure.

The clinical takeaway is that when serous retinal detachment from hypertension appears in a young patient without an obvious reason for extreme blood pressure, the possibility of a hormone-secreting tumor should be on the list. Hypertensive choroidopathy has been documented across a range of underlying causes, including kidney disease, toxemia of pregnancy, and these rare tumors.

Treatment and the Question of Recovery

The primary treatment for serous retinal detachment caused by hypertension is controlling the blood pressure. This is not an eye surgery problem. Once blood pressure comes down to safe levels, the fluid beneath the retina gradually reabsorbs and the retina settles back into place. In the malignant hypertension study mentioned earlier, antihypertensive treatment resolved the acute retinopathy findings, including the serous detachments.

Recovery timelines vary. In some cases, the detachment disappears within about a month of blood pressure normalization. The patient who presented at 206/125 mmHg saw his serous detachments resolve by day 30 of treatment.

The woman with blood pressure of 230/130 recovered 20/20 vision in both eyes after blood pressure control.

In some cases, particularly when the detachment is large or the retinal blood vessels are severely damaged, clinicians have tried intravitreal injections of anti-VEGF medications (the same class used for wet macular degeneration) as an adjunct therapy to reduce vascular leakage while blood pressure is being brought under control.

This remains a case-level intervention rather than a standard recommendation, and blood pressure management is always the foundation of treatment.

One important caveat about blood pressure treatment itself: lowering pressure too quickly in a hypertensive emergency carries its own eye risk. At least one case has documented anterior ischemic optic neuropathy, a form of nerve damage in the eye, caused by excessively rapid correction of malignant hypertension.

This is why hypertensive emergencies are managed in hospital settings with careful, controlled reductions in blood pressure rather than sudden drops.

When Vision Does Not Fully Return

While most patients with hypertensive serous retinal detachment recover good vision, the outcome is not universally perfect. The RPE cells that were damaged by ischemia during the hypertensive crisis do not always fully regenerate. Even after the detachment resolves and the fluid reabsorbs, some patients are left with degenerative changes in the RPE that permanently affect vision.

Residual damage to the choroidal blood supply has also been documented. Even after the acute episode passes and the retina reattaches, imaging studies have shown persistent flow defects in the layer of tiny blood vessels beneath the RPE. These flow defects confirm that the ischemia during the hypertensive crisis caused structural vascular damage that does not entirely reverse.

The practical message is that while the headline story is encouraging (blood pressure control leads to retinal reattachment and vision recovery), the speed and completeness of recovery depend on how long the blood pressure was severely elevated and how much damage accumulated before treatment began. The 50-year-old man mentioned earlier recovered excellent vision in one eye (20/16) but remained at 20/500 in the other, a dramatic asymmetry that likely reflected uneven choroidal damage.

How Eye Imaging Has Changed the Picture

Much of what we understand about how hypertension damages the choroid has been clarified by advances in imaging, particularly optical coherence tomography (OCT), which provides cross-sectional views of retinal layers with microscopic resolution. OCT can reveal subretinal fluid, choroidal thickening, and RPE changes in real time, allowing clinicians to monitor both the severity of the detachment and its response to blood pressure treatment.

Enhanced-depth imaging OCT can measure choroidal thickness directly. In hypertensive choroidopathy, the choroid often swells dramatically. Optical coherence tomography angiography (OCTA), a newer technique that maps blood flow without injecting dye, has been used to demonstrate the reduced blood flow in the choroidal vessels during and after acute hypertensive episodes. Fluorescein angiography, a dye-based test, can show the abnormal pattern of choroidal filling during acute malignant hypertension, including areas where tiny blood vessels have shut down entirely and areas of active fluid leakage.

These tools have moved the understanding of hypertensive retinal detachment from a clinical observation (“we see fluid under the retina”) to a mechanistic one (“we can track the choroidal blood flow that fails and the barrier that breaks down”). For patients, the practical value is that clinicians can now detect milder forms of choroidal damage before a full detachment develops and can track recovery with greater precision during treatment.